Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.
about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationReal-time PCR in clinical microbiology: applications for routine laboratory testing.The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation.Molecular diagnosis of influenza.Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasmaPrecision across the analytical measuring range of a quantitative real-time PCR assay for cytomegalovirus detection among three clinical laboratories.Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assayValganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts.Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients.Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.Clinical features and outcomes of cytomegalovirus retinitis after transplantation.Strategies for managing cytomegalovirus in transplant recipients.Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipientsNormalized quantification of human cytomegalovirus DNA by competitive real-time PCR on the LightCycler instrument.Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNATreatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation.The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries.Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection.Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia.Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.Cytomegalovirus reactivation in a critically ill patient: a case report.
P2860
Q26826856-25EDCB7E-3EDB-4F7A-AACD-1823C620AA15Q27472851-8B3CD0BE-00CE-498C-A9F7-76E55ACB9A8BQ34768066-3061C87A-EE31-45EE-904A-C9321C8A45F6Q34985863-B5281C9B-CCC7-4ED8-BE09-1E65632EDB5BQ34991529-F7A22362-0A9D-4317-8EB1-826100FA5DF0Q35139749-9630F86C-7467-4C79-B71F-D4EB36360E64Q35139837-D3BDA071-635C-460D-A1E3-F3046FF4E304Q35638781-2DBB85C0-91C3-4DC0-BE3C-15836F274609Q35917319-4E897C28-AE0B-47FB-8C7B-6AB86231D9E8Q36452454-9ACCC0B5-AE4D-46D8-B790-3B62F91AA62BQ36597473-68E4B46F-FA52-4CD0-8871-1E715416F5B7Q36826107-42B7932B-C814-449C-A0CB-7CF43FB07F6BQ37773992-61AF9E59-3DB7-47F0-9786-03758EFC9EF3Q39626863-EC563404-40D0-4D00-ACCB-0073A6224E6CQ39732759-76FF49B6-5218-4510-8BB2-BBB0A290545CQ39750937-F7895B95-9836-4685-BAD0-FFFB65E73B0AQ39848377-22A24D26-0806-40BC-A3FA-0DA5E9A83B19Q39848513-46541D29-CCAF-44C1-BCBB-6C2B81B785D2Q40901843-8A8DEBD5-31E2-4AAB-BE71-A39505CD9B6FQ41537054-53468169-5FB7-4BD0-AF7C-13331AA898E1Q42214814-9C541FCF-7B68-4100-AB76-E214103C3467Q43040318-AC933EF4-1CA2-42F7-B957-D4E23B268F54Q43223365-91A8C8DE-CFA5-4FD5-A782-29C023943079Q44412730-D6B163F8-EE5C-4B55-A10E-EC4AA478FF21Q44547572-FB06F32B-659D-409A-9E92-194C515531C3Q44800855-EB960AEF-BE3F-45BB-8EA2-7BF146D3FDFBQ55475470-7B879A1D-AF7B-4F1F-982E-920F9ED72523
P2860
Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparative quantitation of cy ...... -throughput automated systems.
@ast
Comparative quantitation of cy ...... -throughput automated systems.
@en
type
label
Comparative quantitation of cy ...... -throughput automated systems.
@ast
Comparative quantitation of cy ...... -throughput automated systems.
@en
prefLabel
Comparative quantitation of cy ...... -throughput automated systems.
@ast
Comparative quantitation of cy ...... -throughput automated systems.
@en
P2093
P2860
P1476
Comparative quantitation of cy ...... -throughput automated systems.
@en
P2093
Groettum C
Razonable RR
P2860
P304
P356
10.1128/JCM.39.12.4472-4476.2001
P407
P577
2001-12-01T00:00:00Z